S100P is highly expressed in various solid tumors and associated with poor prognosis in CRC (51, 52), breast cancer (53), pancreatic cancer (54), cholangiocarcinoma (55) lung cancer (56), and ovarian cancer (57). This evidence concerns the gene S100P and pancreatic neoplasm.